SMARCA1 and cancer: This study informs how retained SWI/SNF complexes in MRT can converge on multiple oncogenic processes through diverse mechanisms following SNF5 loss and may predict specific oncogenic pathways that become activated across other cancers showing SWI/SNF subunit alteration and mutations.